Apotex 'Thumbing Its Nose' At Paxil Bar, Mylan Says
Generic-drug maker Mylan Inc. has alleged that rival Apotex Inc. continues to sell generic Paxil CR in violation of Mylan's exclusivity agreement with GlaxoSmithKline PLC, despite a New Jersey federal judge's...To view the full article, register now.
Already a subscriber? Click here to view full article